Ключевые слова
Как цитировать
Аннотация
Обзор посвящён использованию свобод-ноциркулирующей Днк (сцДНК) вируса Эпштейна-Барр (EBV) и папилломавируса (HPV) в диагностике онкологических заболеваний. Обобщены результаты исследований последних лет, свидетельствующие о перспективности разработки сцДНК EBV и HPV в качестве диагностических маркёров. Подробно проанализированы противоречия в исследованиях различных авторов, свидетельствующие о необходимости стандартизации исследований для внедрения этих новых маркёров в клиническую практику.
Библиографические ссылки
Сенюта Н.Б., Игнатова А.В., Ломая М.В. и др. Вирус Эпштейна-Барр у больных раком носоглотки и здоровых лиц в двух географически р азличных регионах России // Инфекция и иммунитет. - 2017. - Т. 7. - С. 41-50.
Ahn S., Chan J., Zhang Z. et el. Saliva and plasma quantitative polymerase chain reaction-based detection and surveillance of human papillomavirus-related head and neck cancer. // JAMA Otolaryngol. Head Neck Surg. - 2014. - Vol. 140. - P. 846-854.
Alfieri S., Iacovelli N., Marceglia S. et al. Circulating pretreatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area // Oncotarget. - 2017. - Vol. 8. - P. 47780-47789.
Anker P, Mulcahy H., Qi Chen X. et al. Detection of drculating tumour DNA in the blood (plasma/serum) of cancer patients // Cancer Metastasis Rev. - 1999. - Vol. 18. - P. 65-73.
Campitelli M., Jeannot E., Peter M. et al. Human papillomavirus mutational insertion: specific marker of circulating tumor DNA in Cervical Cancer Patients // PLoS ONE. -2012. - Vol. 7(8). - e43393. - DOI: 10.1371/journal.pone.0043393
The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma // Nature. - 2014. - Vol. 513. - P 202-209.
Cao H., Banh A., Kwok S. Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients // Int. J. Radiat. Oncol. Biol. Phys. - 2012. - Vol. 82(3). - P e351-8. - DOI: 10.1016/j.ijrobp.2011.05.061
Capone R., Pai S., Koch W. et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma // Clin. Cancer Res. - 2000. - Vol. 6. - P. 4171-4175.
Chai R., Lambie D., Verma M., Punyadeera C. Current trends in the etiology and diagnosis of HPV-related head and neck cancers // Cancer Med. - 2015. - Vol. 4. - P. 596-607.
Chai R., Lim Y., Frazer I. et al. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16INK4a expression in head and neck squamous cell carcinoma patients // BMC Cancer. - 2016. - Vol. 16. - P. 178.
Chan A., Hui E., Ngan R. et al. A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT) // J. Clin. Oncol. - 2017. - Vol. 35. - P. 6002.
Chan K., Leung S., Yeung S. et al. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients // Clin. Cancer Res. -2008. - Vol. 14. - P. 4809-4813.
Chan K., Woo J., King A. et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer // N. Engl. J. Med. - 2017. - Vol. 377. - P. 513- 22.
Chan K., Zhang J., Chan A. et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients // Cancer Res. -2003. - Vol. 63. - P. 2028-2032.
Cocuzza C., Martinelli M., Sina F. et al. Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia // PLoS ONE. - 2017. - Vol. 2(11). - P. e0188592.
Combita A., Gheit T., Gonzalez P. et al. Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia // Cancer Prev. Res. (Phila). - 2016. - Vol. 9. - P. 766-771.
Dennis Lo Y, Chan W., Ng E. et al. Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma // Clin. Cancer Research. - 2001. - Vol. 7. - P. 1856-1859.
Dong S., Pai S., Rha S.-H. et al. Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma // Cancer Epidemiol. Biomarkers Prev. - 2002. - Vol. 11. - P. 3-6.
Ducancelle A., Legrand M., Pivert A. et al. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions // Arch Gynecol Obstet. - 2014. - Vol. 290. - P. 299-308.
Gallagher A., Armstrong A., MacKenzie J. et al. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease // Int. J. Cancer. - 1999. - Vol. 84. - P. 442 - 448.
Guerrero-Preston R., Valle B., Jedlicka A. et al. Molecular triage of premalignant lesions in liquid-based cervical cytology and circulating cell-free DNA from urine, using a panel of methylated human papilloma virus and host genes // Cancer Prev. Res. (Phila). - 2016. - Vol. 9. - P. 915-924.
Haverkos B., Huang Y., Gru A. et al. Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas // Int. J. Cancer. - 2017. - Vol. 140. - P. 1899-1906.
He S.-S., Wang Y, Bao Y et al. Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study // Cancer Med. - 2018. - Vol. 7. - P. 1110-1117.
Holmes A., Lameiras S., Jeannot E. et al. Mechanistic signatures of HPV insertions in cervical carcinomas // Genomic Medicine. - 2016. - Vol. 1. - P. 16004. -. DOI: 10.1038/npjgenmed.2016.4
Jeannot E., Becette V., Campitelli M. Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma // J. Path.: Clin. Res. - 2016. - Vol. 2. - P. 201-209.
Kang Z., Stevanovic S., Hinrichs C., Cao L. Circulating cell-free DNA for metastatic cervical cancer detection, genotyping, and monitoring // Clin. Cancer Res. -2017. - Vol. 23. - P. 6856-6862.
Keer S., Tjalma W., Pattyn J. et al. Human papillomavirus genotype and viral load agreement between paired firstvoid urine and clinician-collected cervical samples // Eur. J. Clin. Microbiol. Infect. Dis. - 2018. - Vol. 37. - P. 859-869.
Lam W., Jiang P., Chan K. et al. Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma // PNAS Latest Articles. - 2018. - P. 1-10.
Lee J., Garcia-Murillas I., Cutts R. et al. Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma // Br. J. Cancer. - 2017. - Vol. 117. - P. 876-883.
Lei K., Chan L., Chan W. et al. Quantitative analysis of circulating cell-free Epstein Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies // Br. J. Haematol. - 2000. - Vol. 111. - P. 239-246.
Lévy P., Bartosch B. Metabolic reprogramming: a hallmark of viral Oncogenesis // Oncogene. - 2016. - Vol. 35. - P. 4155-4164.
Limaye A., Huang M., Atienza E. et al. Detection of Epstein-Barr virus DNA in sera from transplant recipients with lymphoproliferative disorders // J. Clin. Microbiol. -1999. -Vol. 37. - P. 1113-1116.
Lin J.-C., Wang W.-Y., Chen K. et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma // N. Engl. J. Med. - 2004. -Vol. 350. - P. 2461-2470.
Liu T., Zheng Z., Pan J. et al. Prognostic role of plasma Epstein-Barr virus DNA load for nasopharyngeal carcinoma: a meta-analysis // Clin. Invest. Med. - 2017. - Vol. 40. - P. E1-E12.
Liu V., Tsang P., Yip A. et al. Low incidence of HPV DNA in sera of pretreatment cervical cancer patients // Gynecol. Oncol. - 2001. - Vol. 82. - P. 269-272.
Li Y, Khin N., Chua M. The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma // Cancer Biol. Med. - 2018. - DOI: 10.20892/j.issn.2095-3941.2017.0176
Lo Y, Chan L., Lo K. et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma // Cancer Res. - 1999. - Vol. 59. - P. 1188-1191.
Lu T., Li J. Clinical applications of urinary cell-free DNA in cancer: current insights and promising future // Am J Cancer Res. - 2017. - Vol. 7. - P. 2318-2332.
Machado A., Da Silva Robaina M., Magalh es De Rezende L. et al. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas // Leuk. Lymphoma. - 2010. - Vol. 51. - P. 1020-1027.
Mallen-St Clair J., Alani M., Wang M., Srivastan E. Human papillomavirus in oropharyngeal cancer: The changing face of a disease // BBA. - 2016. - Vol. 1866. - P. 141-150.
Mazurek A., Rutkowski T., Fiszer-Kierzkowska A. et al. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients // Oral. Oncol. - 2016. - Vol. 54. - P. 36-41.
Mutirangura A., Pornthanakasem W., Theamboonlers A. et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma // Clin. Cancer Res. - 1998. -Vol. 4. - P. 665-669.
Nalliah S., Karikalan B., Kademane K. Multifaceted usage of HPV related tests and products in the management of cervical cancer // Asian Pac. J. Cancer Prev. - 2015. - Vol. 16. - P. 2145-2150.
Ngan R., Yip T., Cheng W.-W. et al. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease // Clin.Cancer Res. - 2002. - Vol. 8. - P. 986-994.
Peng H., Chen L., Chen Y-P. et al. The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database // PLoS ONE. - 2018. - Vol. 13(5). - P. e0196730. - DOI: 10.1371/journal.pone.0196730
Peng H., Guo R., Chen L. et al. Prognostic impact of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma treated using intensity-modulated radiation therapy // Sci. Rep. - 2016. - 22000. - DOI: 10.1038/srep22000
Rutkowski T., Mazurek A., Snietura M. et al. Post-Treatment circulating free HPV DNA as a marker of treatment outcome in patients with HPV-related propharyngeal cancer after radio(chemo)therapy // Cell. Mol. Med. - 2017. - Vol. 3. - № 2. - P. 12. - DOI: 10.21767/25735365.100035
Ryan J., Fan H., Swinnen L. et al. Epstein-Barr Virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies // Diagn. Mol. Pathol. - 2004. - Vol. 13. - P. 61-68.
Sengar M., Chorghe S., Jadhav K. et al. Cell-free Epstein-Barr virus-DNA in patients with nasopharyngeal carcinoma: plasma versus urine // Head Neck. - 2016. - Vol. - Suppl 1. - P. E1666-1673.
Shannon-Lowe C., Rickinson A., Bell A. Epstein-Barr virus-associated lymphomas // Phil. Trans. R. Soc. B. - 2017. - Vol. 372. - P. 20160271. - DOI: 10.1098/rstb.2016.0271
Shoda K., Ichikawa D., Fujita Y et al. Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer // Oncotarget. - 2017. - Vol. 8. -P. 28796-28804.
Song Y, Xiao H., Yang Z. et al. The predictive value of pre- and post-induction chemotherapy plasma EBV DNA level and tumor volume for the radiosensitivity of locally advanced nasopharingeal carcinoma // EXCLI Journal. - 2017. - Vol. 16. - P. 1268-1275.
Stevens S., Vervoort M., van den Brule A. et al. Monitoring of Epstein-Barr virus DNA load in peripheral blood by quantitative competitive PCR // J. Clini. Microbiol. - 1999. - Vol. 37. - P. 2852-2857.
Tshomo U., Franceschi S., Tshokey T. et al. Evaluation of the performance of Human Papillomavirus testing in paired urine and clinician-collected cervical samples among women aged over 30 years in Bhutan // Virology J. - 2017. - Vol. 14. - P. 74. - DOI: 10.1186/s12985-017-0744-2
Udager A., McHugh J. Human papillomavirus-associated neoplasms of the head аnd neck // Surg. Pathol. Clin. - 2017. - Vol. 10. - P. 35-55.
Vo H., Nei W., Hu M., Phyo W. Comparison of circulating tumour cells and circulating cell-free Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma undergoing radiotherapy // Sci. Rep. - 2016. - Vol. 6. - P.13. - DOI: 10.1038/s41598-016-0006-3
Wang L., Wang H., Wang J. et al. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase // Oncotarget. - 2015. - Vol. 6. - P. 30317-30326.
Wang Y., Springer S., Mulvey C. et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas // Sci. Transl. Med. - 2015. - Vol. 7(293). - P. 293ra104. - DOI: 10.1126/scitranslmed.aaa8507
Wasserman J., Rourke R., Purgina B. et al. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours // J. Otolaryngol. Head Neck Surg. - 2017. - Vol. 46. - P.3. - DOI: 10.1186/s40463-016-0179-6
Welch J., Schwartz C., Higman M. et al. Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma // Blood Adv. -2017. - Vol. 1. - P. 681-684.
Westmoreland K., Montgomery N., Stanley C. et al. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi // Int. J. Cancer. - 2017. - Vol. 140. - P. 2509-2516.
Xie M., Wu X., Wang F. et al. Clinical significance of plasma Epstein-Barr virus DNA in pulmonary lymphoepithelioma-like carcinoma (LELC) patients // J. Thorac. Oncol. - 2018. - Vol. 13. - P. 218-227.
Yang H., Liu V., Tsang P. et al. Quantification of human papillomavirus DNA in the plasma of patients with cervical cancer // Int. J. Gynecol. Cancer. - 2004. - Vol. 14. - P. 903-910.
Yang L., Xie S., Feng X. et al. Worldwide prevalence of human papillomavirus and relative risk of prostate cancer: a meta-analysis // Sci. Rep. - 2015. - Vol. 5. - P. 14667. - DOI: 10.1038/srep14667
Zambrano A., Kalantari M., Simoneau A. et al. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the Prostate as a habitat for multiple viral infections // Prostate. - 2002. - Vol. 53. - P. 263-276.
Zhang J., Shu C., Song Y et al. Epstein-Barr virus DNA level as a novel prognostic factor in nasopharyngeal carcinoma: A meta-analysis // Medicine. - 2016. - Vol. 95. - P. 40(e5130). - DOI: 10.1097/MD.0000000000005130
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2019